The Europe OTC Drug and Dietary Supplement market was valued at US$ 85,835.9 million in 2019 and is projected to reach US$ 141,676.3 million by 2027; it is expected to grow at a CAGR of 6.6% during 2020–2027.
The growth of the OTC Drug and Dietary Supplement market is mainly attributed to the factors such as rising general health issues, and preference of OTC drugs are expected to propel the growth of the market. However, stringent government regulation for OTC drugs is the major factor hindering the market growth.
The Germany has observed the fastest growth in the OTC Drug and Dietary Supplement market within the past few years and is expected to lead the market in Europe during the forecast period. The market for OTC drug and dietary supplements is expected to grow due to growing awareness about health and fitness, the ever-increasing geriatric population, and spending out–of–pocket. Furthermore, innovations and increased product launches have fueled market growth in recent years. The market has experienced increased sales in the products for cold, pain management, gastrointestinal diseases, influenza, and dietary supplements such as vitamins and herbal products.
Germany OTC Drug and Dietary Supplement Market Revenue and Forecast to 2027
(US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE OTC DRUG AND DIETARY SUPPLEMENT – MARKET SEGMENTATION
OTC drug and Dietary Supplement– By Product
- Cough and Cold Products
- Vitamins and Dietary Supplements
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Oral Care Products
- Ophthalmic Products
- Antacids
- Feminine Care
- Others
OTC Drug and Dietary Supplement– By Type
- Branded
- Generic
OTC Drug and Dietary Supplement– By Form
- Tablets
- Capsules
- Powders
- Ointments
- Liquid
- Others
OTC Drug and Dietary Supplement – By Distribution Channel
- Hospital and Retail Pharmacies
- Retail Stores
- Online Channels
- Others
By Country
- Germany
- UK
- France
- Italy
- Spain
Company Profiles
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Type, Form, Distribution Channel, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe OTC Drug and Dietary Supplement Market – By Product
1.3.2 Europe OTC Drug and Dietary Supplement Market – By Type
1.3.3 Europe OTC Drug and Dietary Supplement Market – By Form
1.3.4 Europe OTC Drug and Dietary Supplement – By Distribution Channel
1.3.5 Europe OTC Drug and Dietary Supplement Market– By Region
2. OTC Drug and Dietary Supplement Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. OTC Drug and Dietary Supplement – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe
4.3 Expert Opinion
5. Europe OTC Drug and Dietary Supplement Market – Industry Dynamics
5.1 Market Drivers
5.1.1 Rising General Health Issues
5.1.2 Preference for OTC Drugs
5.2 Market Restraints
5.2.1 Stringent Government Regulations For OTC Drugs
5.3 Market Opportunities
5.3.1 Business Expansion Activities by Market Players to Offer Improved OTC Drugs
5.4 Future Trends
5.4.1 Preference of OTC Drugs for Minor Diseases
5.5 Impact Analysis
6. OTC Drug and Dietary Supplement Market – Regional Analysis
6.1 Europe OTC Drug and Dietary Supplement Market Revenue Forecast And Analysis
7. Europe OTC Drug and Dietary Supplement Market Analysis – By Product
7.1 Overview
7.2 OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
7.3 Cough and Cold Products
7.3.1 Overview
7.3.2 Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.4 Vitamins and Dietary Supplements
7.4.1 Overview
7.4.2 Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesics
7.5.1 Overview
7.5.2 Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.6 Gastrointestinal Products
7.6.1 Overview
7.6.2 Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.7 Sleep Aids
7.7.1 Overview
7.7.2 Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.8 Oral Care Products
7.8.1 Overview
7.8.2 Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.9 Ophthalmic Products
7.9.1 Overview
7.9.2 Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.10 Antacids
7.10.1 Overview
7.10.2 Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.11 Feminine Care
7.11.1 Overview
7.11.2 Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
8. OTC Drug and Dietary Supplement Analysis – By Type
8.1 Overview
8.2 OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
8.4 Generic
8.4.1 Overview
8.4.2 Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9. OTC Drug and Dietary Supplement Analysis – By Form
9.1 Overview
9.2 OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)
9.3 Tablets
9.3.1 Overview
9.3.2 Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.4 Capsules
9.4.1 Overview
9.4.2 Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.5 Powders
9.5.1 Overview
9.5.2 Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.6 Ointments
9.6.1 Overview
9.6.2 Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.7 Liquid
9.7.1 Overview
9.7.2 Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10. OTC Drug and Dietary Supplement Analysis – By Distribution Channel
10.1 Overview
10.2 OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)
10.3 Hospital and Retail Pharmacies
10.3.1 Overview
10.3.2 Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Stores
10.4.1 Overview
10.4.2 Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
11. OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 – Geographical Analysis
11.1 Europe: OTC Drug and Dietary Supplement Market
11.1.1 Overview
11.1.2 Europe: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.3 Europe: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.4 Europe: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.5 Europe: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.6 Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.7 Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.1.8 Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Germany: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.8.3 Germany: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.4 Germany: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.8.5 Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.9 France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 France: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.9.3 France: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.4 France: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.9.5 France: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.10 UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 UK: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.10.3 UK: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.4 UK: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.10.5 UK: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.11 Italy: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.11.1 Italy: OTC Drug and Dietary Supplement Market,– Revenue and Forecast to 2027 (USD Million)
11.1.11.2 Italy: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.11.3 Italy: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.11.4 Italy: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.11.5 Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.12 Spain: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Spain: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Spain: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.12.3 Spain: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.12.4 Spain: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.12.5 Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global OTC Drug and Dietary Supplement Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 GlaxoSmithKline plc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AbbVie Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bausch Health Companies Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bayer AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Procter & Gamble
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Novartis AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Reckitt Benckiser Group Plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
14.1.1 Glossary of Terms, OTC Drug and Dietary Supplement
LIST OF TABLES
Table 1. Europe: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. Europe: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Europe: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 4. Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. Germany: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. Germany: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Germany: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. France: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. France: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. France: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 12. France: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. UK: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. UK: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. UK: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 16. UK: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Italy: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Italy: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Italy: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 20. Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Spain: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 22. Spain: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Spain: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 24. Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
LIST OF FIGURES
Figure 1. OTC Drug and Dietary Supplement Market Segmentation
Figure 2. OTC Drug and Dietary Supplement Segmentation – By Region
Figure 3. Europe OTC Drug and Dietary Supplement Market Overview
Figure 4. Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement
Figure 5. OTC Drug and Dietary Supplement Market in Germany to Show Remarkable Growth During Forecast Period
Figure 6. Europe OTC Drug and Dietary Supplement Market- Leading Country Markets (US$ Million)
Figure 7. Europe PEST Analysis
Figure 8. OTC Drug and Dietary Supplement Impact Analysis Of Driver And Restraints
Figure 9. Europe OTC Drug and Dietary Supplement Market – Revenue Forecast And Analysis – 2019- 2027
Figure 10. OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
Figure 11. Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 21. OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
Figure 22. Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 24. OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)
Figure 25. Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 31. OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)
Figure 32. Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Europe: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)
Figure 37. Europe: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 39. Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 40. France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 41. UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 42. Italy: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (USD Million)
Figure 44. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in European Countries
The List of Companies - Europe OTC Drug and Dietary Supplement Market
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe OTC Drug and Dietary Supplement Market
Sep 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Sep 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Sep 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)